BEVERLY, Mass. -- The Environmental Protection Agency (EPA) has recently registered a new product for preventing and eliminating methicillin-resistant Staphylococcus aureus (MRSA).
The EPA has registered Selectrocide chlorine dioxide for use as a disinfectant on hard, non-porous surfaces and instruments, including those used within hospitals and other medical settings. As a no-wipe, no-rinse spray, Selectrocide chlorine dioxide can also be used on hard, non-porous surfaces in health clubs, spas, public places, and swimming facilities as a treatment against MRSA. The EPA has also registered Selectrocide as a disinfectant for vancomycin-resistant Enterococcus faecalis, athletes foot, Mycobacterium bovis (TB) and other pathogens that spread in many environments.
MRSA is usually spread by direct physical contact with those already infected or through indirect contact by touching objects (towels, clothes, sports equipment, etc.) that infected skin has contaminated. Consequently, any heavily trafficked area can be a source of infection.
According to a report by the BBC News, Staphylococcus aureus is the leading cause of human infections in the skin and soft tissues, bones and joints, abscesses and normal heart valves. It flourishes in the hospital setting, producing bloodstream and surgical wound infections, including MRSA.
Selectrocide is greater than 99 percent pure chlorine dioxide, an ideal biocide because of its ability to kill viruses, bacteria, fungi, and algae at low saturation levels (parts per million) in a manner that does not allow pathogens to build resistance to the compound.
Prior to Selectrocide, healthcare and health club environments were limited to using substances such as bleach and quaternary ammonium compounds that can leave residue and require higher concentrations than does chlorine dioxide to achieve the same antimicrobial efficacy.
Selectrocides chlorine dioxide is produced in water and sprayed, mopped, or sponged onto surfaces that require disinfection. After application, the solution is left on target surfaces and does not require rinsing. Due to the comparatively low application concentrations required to kill pathogens, Selectrocide is compatible with most materials.
Formed in 1999, Selective Micro Technologies is a private company based in Beverly, Massachusetts. Combining sophisticated science with innovative product design, Selective Micro has invented a proprietary delivery system that controls the rate and efficiency of gas-producing reactions.
Source: Selective Micro Technologies
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.